Author Profile
More from Bhekisisa Staff …
Superbugs + climate change = double trouble. Here’s why
Here are answers to 11 questions on why drug resistance and climate change are a big public health issue
Our advertising regulator is funded by the food and beverage industry, should it be allowed to block public health messaging?
A pending court complaint alleges bias after the regulator voted to block radio advertisements about the dangers of sugar
HIV made him expect to die at 40. At 73, Edwin Cameron asks: who’s planning for our ageing survivors?
At 33, the now-retired Constitutional Court justice thought he had maybe seven years left. His story traces the arc from certain death from Aids to a chronic, manageable condition at 73
How to decode Big Tobacco’s illicit trade fiction
The tobacco industry is getting ready for the final showdown as the bill heads into its last rounds, pulling out its well-worn talking points on illicit trade and high taxes
Obesity: the chronic disease that isn’t treated like one
A review of 37 studies found that when people stop taking weight-loss drugs like Ozempic, the weight comes back. Researcher Nomathemba Chandiwana says it’s time to start treating obesity like a chronic illness
The real ‘nanny tax’? Not being able to breastfeed your own baby
Many moms who work as domestic workers have to make an impossible choice: keep your job or breastfeed your child, creating a cycle that a decade-old proposal could end
Cutting: why teens turn to self-harm when they don’t have words for their pain
For some teens, emotional pain manifests as cutting, burning, hitting, biting, scratching and picking at skin, behaviour that is not to be confused with being suicidal
LISTEN | One year after Trump: the day HIV funding changed forever — and what came next
Bhekisisa, who have broken many of the major HIV-funding developments since January 2024, speak to Mitchell Warren, the executive director of Avac, a New York-based HIV advocacy organisation
Here’s what’s on South Africa’s 2026 public health agenda
We talked to experts in obesity, tobacco, AI, HIV, TB and the NHI to find out what we can expect — and what we can’t — this year
Aids at 44: will HIV-negative people take anti-HIV jabs?
Twenty-five years ago, South Africans battled for ARVs to keep people alive. Now the focus has shifted to medicines that can prevent HIV altogether. Health Beat looks how the story has evolved




















